Waiting Times for Radiotherapy after Breast-conserving Surgery and the Association with Survival: A Path Analysis

被引:11
作者
Downing, A. [1 ]
Gilthorpe, M. S. [2 ]
Dodwell, D. [3 ]
Lawrence, G. [4 ]
Forman, D. [5 ]
机构
[1] Univ Leeds, St James Univ Hosp, NYCRIS, Inst Oncol,Canc Epidemiol Grp,Ctr Epidemiol & Bio, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Div Biostat, Ctr Biostat & Epidemiol, Leeds LS9 7TF, W Yorkshire, England
[3] St James Hosp, Inst Oncol, Leeds LS9 7TF, W Yorkshire, England
[4] Univ Birmingham, W Midlands Canc Intelligence Unit, Birmingham, W Midlands, England
[5] Int Agcy Res Canc, F-69372 Lyon, France
关键词
Breast cancer; delay; path analysis; radiotherapy; survival; waiting time; CANCER; DELAY; OUTCOMES;
D O I
10.1016/j.clon.2011.02.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aims: To investigate the association between radiotherapy waiting times and survival in women who have undergone breast-conserving surgery using data from two English cancer registry regions. The data were analysed using path analysis to account for the complex variable interrelationships within the data. Materials and methods: Cases of female invasive breast cancer diagnosed during the period 1 January 1998 to 31 December 2005 were identified and linked to an extract of Hospital Episode Statistics data. A subset of these linked records where women underwent breast-conserving surgery was extracted (n = 18,158). Patient, tumour and treatment information were extracted. A path model was developed with three outcome variables: survival, time to receive radiotherapy and receipt of chemotherapy before radiotherapy. Results: During the study period, the median radiotherapy waiting time in region 1 increased from 70 days to 128.5 days. In region 2, the median wait increased from 44 days in 1998 to 68 days in 2001, then decreased to 42 days by 2005. In the path model, radiotherapy waiting time was not associated with survival (hazard ratio = 1.00, 95% confidence interval 0.99-1.01 per week increase in both regions). Patients receiving chemotherapy before radiotherapy waited 12.3 weeks (region 1) and 6.3 weeks (region 2) longer for their radiotherapy than those not receiving chemotherapy. Patients with stage II/III disease waited longer than patients with stage I disease. Younger age, diagnosis of stage II/III disease and presence of co-morbidities were associated with increased odds of receiving chemotherapy before radiotherapy. Conclusions: This study found no association between waiting times for radiotherapy and survival in two regions of England, despite increases in waiting times over the study period. Such an association, if real, may only become apparent after a longer period of follow-up. (C) 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 27 条
[1]
[Anonymous], 2000, NHS CANC PLAN PLAN I
[2]
Re-audit of radiotherapy waiting times 2003 [J].
Ash, D ;
Barrett, A ;
Hinks, A ;
Squire, C .
CLINICAL ONCOLOGY, 2004, 16 (06) :387-394
[3]
EFFECT OF DELAY IN RADIATION IN THE COMBINED MODALITY TREATMENT OF BREAST-CANCER [J].
BUCHHOLZ, TA ;
AUSTINSEYMOUR, MM ;
MOE, RE ;
ELLIS, GK ;
LIVINGSTON, RB ;
PELTON, JG ;
GRIFFIN, TW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (01) :23-35
[4]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]
The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature [J].
Chen, Zheng ;
King, Will ;
Pearcey, Robert ;
Kerba, Marc ;
Mackillop, William J. .
RADIOTHERAPY AND ONCOLOGY, 2008, 87 (01) :3-16
[6]
Cancer care - Waiting for radiotherapy [J].
Dodwell, D ;
Crellin, A .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7533) :107-109
[7]
DRINKWATER KJ, 2007, REAUDIT RADIOTHERAPY
[8]
HARTSELL WF, 1995, CANCER, V76, P2497, DOI 10.1002/1097-0142(19951215)76:12<2497::AID-CNCR2820761214>3.0.CO
[9]
2-6
[10]
A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer [J].
Hébert-Croteau, N ;
Freeman, CR ;
Latreille, J ;
Rivard, M ;
Brisson, J .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (02) :187-196